Ethereum treasury company ETHZilla launches the first tokenized asset backed by aircraft engines
ChainCatcher news, Ethereum treasury company ETHZilla Corporation (NASDAQ: ETHZ), through its wholly-owned subsidiary ETHZilla Aerospace LLC, has launched Eurus Aero Token I, the first tokenized real-world asset backed by commercial aircraft engines.
This token is built on the Ethereum Layer 2 network and is backed by two CFM56 commercial jet engines valued at approximately $12.2 million, which are leased to major U.S. airlines. Each token is priced at $100, with a minimum purchase of 10 tokens, and a target return rate of about 11% if held until the end of the lease term. ETHZilla stated that this product offers qualified investors access to an asset class traditionally limited to private aviation leasing funds or large institutional transactions.
The token will be exclusively available through the Liquidity.io ecosystem, utilizing the ERC-20 token structure, with monthly cash flow distributions to token holders. ETHZilla plans to launch more tokenized asset classes in the near future, including prefabricated home loans and auto loans.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly

XRP Ledger adds account control feature, enabling enterprises to manage assets offline.

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
